A detailed history of Principal Securities, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 517 shares of FOLD stock, worth $5,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
517
Previous 532 2.82%
Holding current value
$5,066
Previous $5.28 Million 4.64%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$9.55 - $12.09 $143 - $181
-15 Reduced 2.82%
517 $5.52 Million
Q2 2024

Jul 31, 2024

SELL
$9.04 - $11.75 $560 - $728
-62 Reduced 10.44%
532 $5.28 Million
Q1 2024

May 10, 2024

BUY
$11.43 - $14.24 $1,485 - $1,851
130 Added 28.02%
594 $7 Million
Q4 2023

Feb 07, 2024

BUY
$9.97 - $14.52 $4,626 - $6,737
464 New
464 $6.58 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.